Individualized medication, medication "vary from person to person" , give full consideration to each patient's genetic factors, gender, age, body weight, physiological and pathological characteristics, and are taking other drugs on the basis of the comprehensive situation of safe, reasonable, effective and economic drug treatment.
Market Analysis and Insights: Global Personalized Medicine Market
The global Personalized Medicine market size is projected to reach US$ 540120 million by 2028, from US$ 259380 million in 2021, at a CAGR of 10.9% during 2022-2028.
Fully considering the economic change by this health crisis, Personalized Medicine Diagnostics accounting for % of the Personalized Medicine global market in 2021, is projected to value US$ million by 2028, growing at a revised % CAGR in the post-COVID-19 period. While Oncology segment is altered to an % CAGR throughout this forecast period.
China Personalized Medicine market size is valued at US$ million in 2021, while the North America and Europe Personalized Medicine are US$ million and US$ million, severally. The proportion of the North America is % in 2021, while China and Europe are % and % respectively, and it is predicted that China proportion will reach % in 2028, trailing a CAGR of % through the analysis period. Japan, South Korea, and Southeast Asia are noteworthy markets in Asia, with CAGR %, %, and % respectively for the next 6-year period. As for the Europe Personalized Medicine landscape, Germany is projected to reach US$ million by 2028 trailing a CAGR of % over the forecast period.
With industry-standard accuracy in analysis and high data integrity, the report makes a brilliant attempt to unveil key opportunities available in the global Personalized Medicine market to help players in achieving a strong market position. Buyers of the report can access verified and reliable market forecasts, including those for the overall size of the global Personalized Medicine market in terms of revenue.
Overall, the report proves to be an effective tool that players can use to gain a competitive edge over their competitors and ensure lasting success in the global Personalized Medicine market. All of the findings, data, and information provided in the report are validated and revalidated with the help of trustworthy sources. The analysts who have authored the report took a unique and industry-best research and analysis approach for an in-depth study of the global Personalized Medicine market.
Global Personalized Medicine Scope and Market Size
Personalized Medicine market is segmented by players, region (country), by Type and by Application. Players, stakeholders, and other participants in the global Personalized Medicine market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application for the period 2017-2028.
Segment by Type
- Personalized Medicine Diagnostics
- Personalized Medical Care
- Personalized Medicine Therapeutics
- Personalized Nutrition and Wellness
Segment by Application
- Oncology
- Central Nervous System (CNS)
- Immunology
- Respiratory
- Other Applications
By Company
- Abbott Laboratories
- Agilent Technologies
- Amgen
- Astellas Pharma
- Astrazeneca
- Bayer AG
- Celgene Corporation
- Glaxosmithkline Plc
- Illumina
- Johnson & Johnson
- Laboratory Corporation
- Merck
- Novartis AG
- Roche Holding AG
- Siemens AG
- Takeda Pharmaceutical Company Limited
By Region
- North America
- Europe
- Germany
- France
- UK
- Italy
- Russia
- Nordic Countries
- Rest of Europe
- Asia-Pacific
- China
- Japan
- South Korea
- Southeast Asia
- India
- Australia
- Rest of Asia
- Latin America
- Mexico
- Brazil
- Rest of Latin America
- Middle East & Africa
- Turkey
- Saudi Arabia
- UAE
- Rest of MEA
TABLE OF CONTENTS
1 Report Business Overview
- 1.1 Study Scope
- 1.2 Market Analysis by Type
- 1.2.1 Global Personalized Medicine Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
- 1.2.2 Personalized Medicine Diagnostics
- 1.2.3 Personalized Medical Care
- 1.2.4 Personalized Medicine Therapeutics
- 1.2.5 Personalized Nutrition and Wellness
- 1.3 Market by Application
- 1.3.1 Global Personalized Medicine Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
- 1.3.2 Oncology
- 1.3.3 Central Nervous System (CNS)
- 1.3.4 Immunology
- 1.3.5 Respiratory
- 1.3.6 Other Applications
- 1.4 Study Objectives
- 1.5 Years Considered
2 Global Growth Trends
- 2.1 Global Personalized Medicine Market Perspective (2017-2028)
- 2.2 Personalized Medicine Growth Trends by Region
- 2.2.1 Personalized Medicine Market Size by Region: 2017 VS 2021 VS 2028
- 2.2.2 Personalized Medicine Historic Market Size by Region (2017-2022)
- 2.2.3 Personalized Medicine Forecasted Market Size by Region (2023-2028)
- 2.3 Personalized Medicine Market Dynamics
- 2.3.1 Personalized Medicine Industry Trends
- 2.3.2 Personalized Medicine Market Drivers
- 2.3.3 Personalized Medicine Market Challenges
- 2.3.4 Personalized Medicine Market Restraints
3 Competition Landscape by Key Players
- 3.1 Global Top Personalized Medicine Players by Revenue
- 3.1.1 Global Top Personalized Medicine Players by Revenue (2017-2022)
- 3.1.2 Global Personalized Medicine Revenue Market Share by Players (2017-2022)
- 3.2 Global Personalized Medicine Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
- 3.3 Players Covered: Ranking by Personalized Medicine Revenue
- 3.4 Global Personalized Medicine Market Concentration Ratio
- 3.4.1 Global Personalized Medicine Market Concentration Ratio (CR5 and HHI)
- 3.4.2 Global Top 10 and Top 5 Companies by Personalized Medicine Revenue in 2021
- 3.5 Personalized Medicine Key Players Head office and Area Served
- 3.6 Key Players Personalized Medicine Product Solution and Service
- 3.7 Date of Enter into Personalized Medicine Market
- 3.8 Mergers & Acquisitions, Expansion Plans
4 Personalized Medicine Breakdown Data by Type
- 4.1 Global Personalized Medicine Historic Market Size by Type (2017-2022)
- 4.2 Global Personalized Medicine Forecasted Market Size by Type (2023-2028)
5 Personalized Medicine Breakdown Data by Application
- 5.1 Global Personalized Medicine Historic Market Size by Application (2017-2022)
- 5.2 Global Personalized Medicine Forecasted Market Size by Application (2023-2028)
6 North America
- 6.1 North America Personalized Medicine Market Size (2017-2028)
- 6.2 North America Personalized Medicine Market Size by Type
- 6.2.1 North America Personalized Medicine Market Size by Type (2017-2022)
- 6.2.2 North America Personalized Medicine Market Size by Type (2023-2028)
- 6.2.3 North America Personalized Medicine Market Share by Type (2017-2028)
- 6.3 North America Personalized Medicine Market Size by Application
- 6.3.1 North America Personalized Medicine Market Size by Application (2017-2022)
- 6.3.2 North America Personalized Medicine Market Size by Application (2023-2028)
- 6.3.3 North America Personalized Medicine Market Share by Application (2017-2028)
- 6.4 North America Personalized Medicine Market Size by Country
- 6.4.1 North America Personalized Medicine Market Size by Country (2017-2022)
- 6.4.2 North America Personalized Medicine Market Size by Country (2023-2028)
- 6.4.3 U.S.
- 6.4.4 Canada
7 Europe
- 7.1 Europe Personalized Medicine Market Size (2017-2028)
- 7.2 Europe Personalized Medicine Market Size by Type
- 7.2.1 Europe Personalized Medicine Market Size by Type (2017-2022)
- 7.2.2 Europe Personalized Medicine Market Size by Type (2023-2028)
- 7.2.3 Europe Personalized Medicine Market Share by Type (2017-2028)
- 7.3 Europe Personalized Medicine Market Size by Application
- 7.3.1 Europe Personalized Medicine Market Size by Application (2017-2022)
- 7.3.2 Europe Personalized Medicine Market Size by Application (2023-2028)
- 7.3.3 Europe Personalized Medicine Market Share by Application (2017-2028)
- 7.4 Europe Personalized Medicine Market Size by Country
- 7.4.1 Europe Personalized Medicine Market Size by Country (2017-2022)
- 7.4.2 Europe Personalized Medicine Market Size by Country (2023-2028)
- 7.4.3 Germany
- 7.4.4 France
- 7.4.5 U.K.
- 7.4.6 Italy
- 7.4.7 Russia
- 7.4.8 Nordic Countries
8 Asia-Pacific
- 8.1 Asia-Pacific Personalized Medicine Market Size (2017-2028)
- 8.2 Asia-Pacific Personalized Medicine Market Size by Type
- 8.2.1 Asia-Pacific Personalized Medicine Market Size by Type (2017-2022)
- 8.2.2 Asia-Pacific Personalized Medicine Market Size by Type (2023-2028)
- 8.2.3 Asia-Pacific Personalized Medicine Market Share by Type (2017-2028)
- 8.3 Asia-Pacific Personalized Medicine Market Size by Application
- 8.3.1 Asia-Pacific Personalized Medicine Market Size by Application (2017-2022)
- 8.3.2 Asia-Pacific Personalized Medicine Market Size by Application (2023-2028)
- 8.3.3 Asia-Pacific Personalized Medicine Market Share by Application (2017-2028)
- 8.4 Asia-Pacific Personalized Medicine Market Size by Region
- 8.4.1 Asia-Pacific Personalized Medicine Market Size by Region (2017-2022)
- 8.4.2 Asia-Pacific Personalized Medicine Market Size by Region (2023-2028)
- 8.4.3 China
- 8.4.4 Japan
- 8.4.5 South Korea
- 8.4.6 Southeast Asia
- 8.4.7 India
- 8.4.8 Australia
9 Latin America
- 9.1 Latin America Personalized Medicine Market Size (2017-2028)
- 9.2 Latin America Personalized Medicine Market Size by Type
- 9.2.1 Latin America Personalized Medicine Market Size by Type (2017-2022)
- 9.2.2 Latin America Personalized Medicine Market Size by Type (2023-2028)
- 9.2.3 Latin America Personalized Medicine Market Share by Type (2017-2028)
- 9.3 Latin America Personalized Medicine Market Size by Application
- 9.3.1 Latin America Personalized Medicine Market Size by Application (2017-2022)
- 9.3.2 Latin America Personalized Medicine Market Size by Application (2023-2028)
- 9.3.3 Latin America Personalized Medicine Market Share by Application (2017-2028)
- 9.4 Latin America Personalized Medicine Market Size by Country
- 9.4.1 Latin America Personalized Medicine Market Size by Country (2017-2022)
- 9.4.2 Latin America Personalized Medicine Market Size by Country (2023-2028)
- 9.4.3 Mexico
- 9.4.4 Brazil
10 Middle East & Africa
- 10.1 Middle East & Africa Personalized Medicine Market Size (2017-2028)
- 10.2 Middle East & Africa Personalized Medicine Market Size by Type
- 10.2.1 Middle East & Africa Personalized Medicine Market Size by Type (2017-2022)
- 10.2.2 Middle East & Africa Personalized Medicine Market Size by Type (2023-2028)
- 10.2.3 Middle East & Africa Personalized Medicine Market Share by Type (2017-2028)
- 10.3 Middle East & Africa Personalized Medicine Market Size by Application
- 10.3.1 Middle East & Africa Personalized Medicine Market Size by Application (2017-2022)
- 10.3.2 Middle East & Africa Personalized Medicine Market Size by Application (2023-2028)
- 10.3.3 Middle East & Africa Personalized Medicine Market Share by Application (2017-2028)
- 10.4 Middle East & Africa Personalized Medicine Market Size by Country
- 10.4.1 Middle East & Africa Personalized Medicine Market Size by Country (2017-2022)
- 10.4.2 Middle East & Africa Personalized Medicine Market Size by Country (2023-2028)
- 10.4.3 Turkey
- 10.4.4 Saudi Arabia
- 10.4.5 UAE
11 Key Players Profiles
- 11.1 Abbott Laboratories
- 11.1.1 Abbott Laboratories Company Details
- 11.1.2 Abbott Laboratories Business Overview
- 11.1.3 Abbott Laboratories Personalized Medicine Introduction
- 11.1.4 Abbott Laboratories Revenue in Personalized Medicine Business (2017-2022)
- 11.1.5 Abbott Laboratories Recent Developments
- 11.2 Agilent Technologies
- 11.2.1 Agilent Technologies Company Details
- 11.2.2 Agilent Technologies Business Overview
- 11.2.3 Agilent Technologies Personalized Medicine Introduction
- 11.2.4 Agilent Technologies Revenue in Personalized Medicine Business (2017-2022)
- 11.2.5 Agilent Technologies Recent Developments
- 11.3 Amgen
- 11.3.1 Amgen Company Details
- 11.3.2 Amgen Business Overview
- 11.3.3 Amgen Personalized Medicine Introduction
- 11.3.4 Amgen Revenue in Personalized Medicine Business (2017-2022)
- 11.3.5 Amgen Recent Developments
- 11.4 Astellas Pharma
- 11.4.1 Astellas Pharma Company Details
- 11.4.2 Astellas Pharma Business Overview
- 11.4.3 Astellas Pharma Personalized Medicine Introduction
- 11.4.4 Astellas Pharma Revenue in Personalized Medicine Business (2017-2022)
- 11.4.5 Astellas Pharma Recent Developments
- 11.5 Astrazeneca
- 11.5.1 Astrazeneca Company Details
- 11.5.2 Astrazeneca Business Overview
- 11.5.3 Astrazeneca Personalized Medicine Introduction
- 11.5.4 Astrazeneca Revenue in Personalized Medicine Business (2017-2022)
- 11.5.5 Astrazeneca Recent Developments
- 11.6 Bayer AG
- 11.6.1 Bayer AG Company Details
- 11.6.2 Bayer AG Business Overview
- 11.6.3 Bayer AG Personalized Medicine Introduction
- 11.6.4 Bayer AG Revenue in Personalized Medicine Business (2017-2022)
- 11.6.5 Bayer AG Recent Developments
- 11.7 Celgene Corporation
- 11.7.1 Celgene Corporation Company Details
- 11.7.2 Celgene Corporation Business Overview
- 11.7.3 Celgene Corporation Personalized Medicine Introduction
- 11.7.4 Celgene Corporation Revenue in Personalized Medicine Business (2017-2022)
- 11.7.5 Celgene Corporation Recent Developments
- 11.8 Glaxosmithkline Plc
- 11.8.1 Glaxosmithkline Plc Company Details
- 11.8.2 Glaxosmithkline Plc Business Overview
- 11.8.3 Glaxosmithkline Plc Personalized Medicine Introduction
- 11.8.4 Glaxosmithkline Plc Revenue in Personalized Medicine Business (2017-2022)
- 11.8.5 Glaxosmithkline Plc Recent Developments
- 11.9 Illumina
- 11.9.1 Illumina Company Details
- 11.9.2 Illumina Business Overview
- 11.9.3 Illumina Personalized Medicine Introduction
- 11.9.4 Illumina Revenue in Personalized Medicine Business (2017-2022)
- 11.9.5 Illumina Recent Developments
- 11.10 Johnson & Johnson
- 11.10.1 Johnson & Johnson Company Details
- 11.10.2 Johnson & Johnson Business Overview
- 11.10.3 Johnson & Johnson Personalized Medicine Introduction
- 11.10.4 Johnson & Johnson Revenue in Personalized Medicine Business (2017-2022)
- 11.10.5 Johnson & Johnson Recent Developments
- 11.11 Laboratory Corporation
- 11.11.1 Laboratory Corporation Company Details
- 11.11.2 Laboratory Corporation Business Overview
- 11.11.3 Laboratory Corporation Personalized Medicine Introduction
- 11.11.4 Laboratory Corporation Revenue in Personalized Medicine Business (2017-2022)
- 11.11.5 Laboratory Corporation Recent Developments
- 11.12 Merck
- 11.12.1 Merck Company Details
- 11.12.2 Merck Business Overview
- 11.12.3 Merck Personalized Medicine Introduction
- 11.12.4 Merck Revenue in Personalized Medicine Business (2017-2022)
- 11.12.5 Merck Recent Developments
- 11.13 Novartis AG
- 11.13.1 Novartis AG Company Details
- 11.13.2 Novartis AG Business Overview
- 11.13.3 Novartis AG Personalized Medicine Introduction
- 11.13.4 Novartis AG Revenue in Personalized Medicine Business (2017-2022)
- 11.13.5 Novartis AG Recent Developments
- 11.14 Roche Holding AG
- 11.14.1 Roche Holding AG Company Details
- 11.14.2 Roche Holding AG Business Overview
- 11.14.3 Roche Holding AG Personalized Medicine Introduction
- 11.14.4 Roche Holding AG Revenue in Personalized Medicine Business (2017-2022)
- 11.14.5 Roche Holding AG Recent Developments
- 11.15 Siemens AG
- 11.15.1 Siemens AG Company Details
- 11.15.2 Siemens AG Business Overview
- 11.15.3 Siemens AG Personalized Medicine Introduction
- 11.15.4 Siemens AG Revenue in Personalized Medicine Business (2017-2022)
- 11.15.5 Siemens AG Recent Developments
- 11.16 Takeda Pharmaceutical Company Limited
- 11.16.1 Takeda Pharmaceutical Company Limited Company Details
- 11.16.2 Takeda Pharmaceutical Company Limited Business Overview
- 11.16.3 Takeda Pharmaceutical Company Limited Personalized Medicine Introduction
- 11.16.4 Takeda Pharmaceutical Company Limited Revenue in Personalized Medicine Business (2017-2022)
- 11.16.5 Takeda Pharmaceutical Company Limited Recent Developments
12 Analyst's Viewpoints/Conclusions
13 Appendix
- 13.1 Research Methodology
- 13.1.1 Methodology/Research Approach
- 13.1.2 Data Source
- 13.2 Author Details
- 13.3 Disclaimer